AUDIO –Science Friday Article
CAR T cell therapy, a type of immunotherapy in which a patient’s own immune cells are modified to create a hybrid immune cell that destroys cancer cells, was first developed over a decade ago.
Now, researchers are continuing to find success in treating new types of blood cancers with the therapy, and are working on applying the technology to solid state cancers like those of the pancreas and brain.
Scientists are also at the early stages of testing CAR T cells to treat autoimmune diseases like multiple sclerosis (MS) and lupus.
Ira talks with Dr. Carl June, one of the pioneers of CAR T cell therapy, a professor of immunotherapy and director of the Center for Cellular Immunotherapies at the University of Pennsylvania, based in Philadelphia.
